UlasDardaBayraktarMD

PubMed

• 19 citations
  Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation
  Ulas D. Bayraktar, Denái R. Milton, Michele Guindani, Gabriela Rondon, Julianne Chen
  Biology of Blood and Marrow Transplantation. 2016-03-01
• 7 citations
  Comparison of cancer care and outcomes between a public safety-net hospital and a private cancer center
  Ulas Darda Bayraktar, Sean Warsch, Emerson Y. Chen, Caio Max S. Rocha Lima, Denise Pereira
  Journal of Health Care for the Poor and Underserved. 2013-08-01
• 192 citations
  Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
  Stefan O. Ciurea, Victor E. Mulanovich, Rima M. Saliba, Ulas D. Bayraktar, Ying Jiang
  Biology of Blood and Marrow Transplantation. 2012-12-01

Journal Articles

• The role of tyrosine kinase inhibitors in the treatment of advanced hepatocellular carcinoma.  
  Bayraktar UD, Journal of Hepato-Gastroenterology

Books/Book Chapters

• Veno-occlusive disease (VOD) oder sinusoidales Obstruktionssyndrom. 
  Poetzsch ÜB, Bayraktar UDEditors: Madlener K, Poetzsch UB.Hämostaseologie, Springer-Verlag, Berlin

Abstracts/Posters

• High-Dose Methotrexate and Azidothymidine in Combination with Alternating DA-EPOCH Is An Effective Regimen for the Treatment of EBV-Related Plasmablastic Lymphoma.
  Bayraktar UD, Ochoa R, Bayraktar S, Matsangou M, Ramos JC, Blood (ASH Annual Meeting Abstracts)
• Desmoid tumor disguised as a pleural lesion.
  Theophyllus E, Bayraktar UD, Schmidt S, et al, Chest
• Catastrophic antiphospholipid syndrome (CAPS): Comparison between primary CAPS and lupus-associated CAPS.
  Bayraktar UD, Erkan D, Asherson R, et al, Arth Rheumat
• Catastrophic antiphospholipid syndrome (CAPS): Poor prognostic factors for mortality.
  Bayraktar UD, Erkan D, Asherson R, et al, Arth Rheumat
• Characteristics of patients with reflux esophagitis, non-erosive reflux disease, and functional heartburn.
  Seren S, Bayraktar UD, Ehrinpreis MN, Am J Gastroenterol
• Catastrophic antiphospholipid syndrome (CAPS): comparison between CAPS patients with and without thrombocytopenia.
  Bayraktar UD, Erkan D, Asherson R, et al, Clin Exp Rheumatol
• An Unusual Presentation of Acute Biphenotypic Leukemia without Bone Marrow Involvement.
  Bayraktar UD, Escalon M, Blood (ASH Annual Meeting Abstracts)
• Neoadjuvant dose-dense docetaxel, carboplatinum, and trastuzumab (ddTCH) chemotherapy for HER2 overexpressing breast cancer.
  Bayraktar S, Bayraktar UD, Reis IM, et al, J Clin Oncol 27
• Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer?
  Bayraktar UD, Bayraktar S, Herna S, et al, J Clin Oncol 27
• A retrospective study of neoadjuvant DCF (docetaxel, cisplatin, 5-fluorouracil) for locally advanced gastric or gastroesophageal junction adenocarcinoma (GC).
  Castellanos R, Ernani V, Bayraktar UD, et al, J Clin Oncol
• Primary CNS lymphoma in HIV-positive and -negative patients: Comparison of clinical characteristics, outcome, and prognostic factors.
  Bayraktar S, Bayraktar UD, Stefanovic A, Lossos IS, J Clin Oncol 28
• The Use of High-Dose Azidothymidine Plus Methotrexate alone or in Combination with Conventional Chemotherapy is an Effective Approach.
  Bayraktar UD, Bernal E, Cabral L, et al, Infectious Agents and Cancer
• Outcome of patients with relapsed/refractory aids-related lymphoma.
  Noy A, Bayraktar UD, Gupta N, Moore P, Lensing S, Blood (ASH Annual Meeting Abstracts)
• Chromosome 7 abnormalities in allogeneic transplantation for AML and MDS.
  Kota V, Saliba RM, Bayraktar UD, et al, Blood (ASH Annual Meeting Abstracts)
• Improved early outcomes with T-cell replete (TCR) compared with T-cell depleted (TCD) haploidentical stem cell transplantation (HaploSCT).
  Ciurea SO, Saliba RM, Bayraktar UD, et al, Blood (ASH Annual Meeting Abstracts)
• Ex-vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission: A comparison of outcomes in two institutions.
  Bayraktar UD, Shpall EJ, Liu P, et al, Blood (ASH Annual Meeting Abstracts)
• Hematopoietic Cell Transplantation - Specific Comorbidity Index as an instrument to predict survival in patients admitted to intensive care unit early after allogeneic...
  Bayraktar UD, Shpall EJ, Liu P, et al, Blood (ASH Annual Meeting Abstracts)
• Relevance and factors predicting for early lymphocyte recovery after allogeneic bone marrow stem cell transplantation (BMT).
  Bayraktar UD, Saliba RM, Rondon G, et al, Blood (ASH Annual Meeting Abstracts)
• Join now to see all

Lectures

• Hematopoietic Cell Transplantation - Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic... 
  53rd ASH Annual Meeting and Exposition, San Diego, CA
• Tyrosine kinase inhibitors in the treatment of hepatocellular carcinoma. 
  International Association of Surgeons, Gastroenterologists, and Oncologists, Istanbul, Turkey
• Relevance and factors predicting for early lymphocyte recovery after allogeneic bone marrow stem cell transplantation. 
  54th ASH Annual Meeting and Exposition, Atlanta, GA
• Ex-Vivo T Cell-Depleted Versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission: A Comparison of Outcomes in Two Institutions. 
  53rd ASH Annual Meeting and Exposition, San Diego, CA
• Outcome of patients with relapsed/refractory aids-related lymphoma. 
  52nd ASH Annual Meeting and Exposition, Orlando, FL
• The Use of High-Dose Azidothymidine Plus Methotrexate alone or in Combination with Conventional Chemotherapy is an Effective Approach. 
  12th ICMAOI Meeting, Bethesda, MD
• Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer? 
  ASCO 2009 Annual Meeting, Orlando, FL
• Precipitating Factors in Catastrophic Antiphospholipid Syndrome. 
  12th International Congress on Antiphospholipid Antibodies, Florence, Italy
• Catastrophic antiphospholipid syndrome (CAPS): comparison between CAPS patients with and without thrombocytopenia. 
  12th International Congress on Antiphospholipid Antibodies, Florence, Italy
• Catastrophic antiphospholipid syndrome (CAPS): Poor prognostic factors for mortality. 
  American College of Rheumatology Meeting, San Diego, CA
• Catastrophic antiphospholipid syndrome (CAPS): Comparison between primary CAPS and lupus-associated CAPS. 
  American College of Rheumatology Meeting, San Diego, CA
• Join now to see all

Other

• Successful treatment of anal gland adenocarcinoma with combined modality therapy. 
  Warsch S, Bayraktar UD, Wen B, Zeitouni J, Marchetti F, Rocha-Lima CM, Montero AJ
• Outcome of patients with relapsed/refractory AIDS-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS malignancy consortium. 
  Bayraktar UD, Ramos JC, Petrich A, et al
• Vitamin D receptor upregulation in alloreactive human T cells. 
  Joseph RW, Bayraktar UD, Kim TK, et al
• Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib. 
  Sharma M, Ravandi F, Bayraktar UD, et al
• High dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma. 
  Bayraktar UD, Warsch S, Pereira D
• Primary ocular adnexal MALT lymphoma: Single institution experience in a large cohort of patients. 
  Bayraktar S, Bayraktar UD, Stefanovic A, Lossos IS
• The clinical spectrum of catastrophic antiphospholipid syndrome in the presence or absence of lupus. 
  Bayraktar UD, Erkan D, Bucciarelli S, et al
• Determining domestic formaldehyde levels in Ankara, Turkey. 
  Vaizoglu SA, Aycan S, Deveci MA, Acer T, Bulut B, Bayraktar UD, Akyollu B, Celik M, Arslan U, Akpinar F, Baris Z, Arslan S, Deniz A, Evci ED, Guler C
• Hepatic Venous Outflow Obstruction. 
  Bayraktar UD, Seren S, Bayraktar Y
• Join now to see all